Register for streaming realtime charts, analysis tools, and prices.

Get Started

ABBV

AbbVie (ABBV)

AbbVie Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 Next >>

Date	Time	Source	Headline	Symbol	Company
09/13/2021	11:25AM	Dow Jones News	Regenxbio Shares Jump After Collaborating With AbbVie on Eye Therapy	NYSE:ABBV	AbbVie Inc
09/13/2021	7:11AM	Dow Jones News	AbbVie, Regenxbio to Partner on Eye Therapy	NYSE:ABBV	AbbVie Inc
09/13/2021	6:30AM	PR Newswire (US)	AbbVie and REGENXBIO Announce Eye Care Collaboration	NYSE:ABBV	AbbVie Inc
09/10/2021	5:02PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
09/10/2021	10:27AM	PR Newswire (US)	AbbVie Declares Quarterly Dividend	NYSE:ABBV	AbbVie Inc
09/10/2021	9:00AM	PR Newswire (US)	AbbVie to Highlight Its Leadership in Movement Disorders at the International Parkinson and Movement Disorder Society Virtual Congress 2021	NYSE:ABBV	AbbVie Inc
09/09/2021	8:00AM	PR Newswire (US)	AbbVie to Present at the Morgan Stanley Healthcare Conference	NYSE:ABBV	AbbVie Inc
09/09/2021	7:00AM	PR Newswire (US)	Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (B-NHL) Published in The Lancet	NYSE:ABBV	AbbVie Inc
09/09/2021	7:00AM	Business Wire	Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell non-Hodgkin’s Lymphoma (B-NHL) Published in The Lancet	NYSE:ABBV	AbbVie Inc
09/08/2021	9:10AM	PR Newswire (US)	AbbVie to Present Data From Its Migraine Portfolio at the 2021 International Headache Congress	NYSE:ABBV	AbbVie Inc
09/02/2021	6:05AM	TipRanks	Is AbbVie’s Arthritis “Heartache” Curable?	NYSE:ABBV	AbbVie Inc
09/01/2021	12:15PM	Dow Jones News	AbbVie Down Over 8%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk	NYSE:ABBV	AbbVie Inc
08/30/2021	5:30AM	TipRanks	5 Top Dividend Stocks for September 2021	NYSE:ABBV	AbbVie Inc
08/26/2021	10:01AM	PR Newswire (Canada)	AbbVie Receives a Positive Reimbursement Recommendation from the Canadian Agencies for Drugs and Technology in Health (CADTH) pan-Canadian Oncology Drug Review Expert Review Committee (pERC) for VENCLEXTA® (venetoclax) in Combination with azacitidine f...	NYSE:ABBV	AbbVie Inc
08/26/2021	10:01AM	PR Newswire (Canada)	AbbVie reçoit une recommandation favorable de la part du Comité d'experts en examen du Programme pancanadien d'évaluation des anticancéreux (PPEA) de l'Agence canadienne des médicaments et des technologies de la santé (ACMTS) pour le remboursement...	NYSE:ABBV	AbbVie Inc
08/25/2021	6:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
08/25/2021	6:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
08/24/2021	8:41AM	Dow Jones News	AbbVie Gets European OK of Rinvoq in Atopic Dermatitis	NYSE:ABBV	AbbVie Inc
08/24/2021	8:00AM	PR Newswire (US)	European Commission Approves RINVOQ® (upadacitinib) as First JAK Inhibitor in the European Union for the Treatment of Both Adults and Adolescents with Moderate to Severe Atopic Dermatitis	NYSE:ABBV	AbbVie Inc
08/19/2021	2:38PM	Dow Jones News	AbbVie Says Court Rules Imbruvica Patents Valid in Generic Challenge	NYSE:ABBV	AbbVie Inc
08/18/2021	5:28PM	PR Newswire (US)	New England Journal of Medicine Publishes 12-Week Results from Study Evaluating Atogepant for the Preventive Treatment of Migraine	NYSE:ABBV	AbbVie Inc
08/09/2021	8:45AM	PR Newswire (US)	SKYRIZI® (risankizumab-rzaa) Now Available in the U.S. as a Single 150 mg Injection for Adults with Moderate to Severe Plaque Psoriasis	NYSE:ABBV	AbbVie Inc
08/06/2021	4:24AM	Dow Jones News	Takeda Pharmaceutical Revises Lower First-Quarter Net Profit on Tax Provision	NYSE:ABBV	AbbVie Inc
08/04/2021	12:01PM	PR Newswire (US)	JAMA Dermatology Publishes Data Showing RINVOQ® (upadacitinib) Achieved Superiority Versus DUPIXENT® (dupilumab) for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis	NYSE:ABBV	AbbVie Inc
08/02/2021	8:02AM	TipRanks	AbbVie: Analysts Bullish After Solid Q2, Positive Outlook	NYSE:ABBV	AbbVie Inc
08/01/2021	11:00AM	TipRanks	5 Top Dividend Stocks for August 2021	NYSE:ABBV	AbbVie Inc
07/30/2021	7:44AM	PR Newswire (US)	AbbVie Reports Second-Quarter 2021 Financial Results	NYSE:ABBV	AbbVie Inc
07/29/2021	9:12AM	Dow Jones News	Allergan's Botox Gets FDA OK for More Muscles in Adult Spasticity	NYSE:ABBV	AbbVie Inc
07/29/2021	8:30AM	PR Newswire (US)	FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity	NYSE:ABBV	AbbVie Inc
07/27/2021	7:33PM	Benzinga	Earning Reports Fom Household Names This Week. PART 1	NYSE:ABBV	AbbVie Inc

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 Next >>

FBEC Worldwide (CE)

Movement Industries (PK)

ERHC Energy (CE)

Elite Pharmaceuticals (QB)

Decentral Life (PK)

Anavex Life Sciences

Kraig Biocraft Laborator... (QB)

Voip Pal Com (QB)

Asia Broadband (PK)

Fannie Mae (QB)

Good Vibrations Shoes (PK)

Bioelectronics (PK)

Delayed Upgrade Clock